Table 2 Bivariate analysis of the fatty acid profiling
Fatty acid fractionation | Preeclampsia (n = 34) | Normotensive (n = 32) | P-value |
|---|---|---|---|
LCPUFA, | 5750.67 ± 1476.53 | 5706.87 ± 977.46 | 0.887 |
w6/w3 ratio | 11.36 ± 3.40 | 10.94 ± 3.12 | 0.633 |
AA/EPA ratio | 36.50 (9.00–134.00) | 44.00 (10.00–116.0) | 0.130a |
AA/DHA ratio | 1.66 ± 0.387 | 1.49 ± 0.369 | 0.077 |
Total Omega-3 | 494.64 ± 171.00 | 510.53 ± 157.47 | 0.618 |
w3 index | 3.00 (2.00–6.00) | 4.00 (2.00–5.00) | 0.159a |
ALA (C18:3 w3) | 40.79 ± 17.70 | 40.15 ± 15.61 | 0.877 |
EPA (C20:5 w3) | 24.67 ± 23.63 | 18.34 ± 15.88 | 0.111 |
DHA (C22:6 w3) | 429.26 ± 145.59 | 451.87 ± 137.81 | 0.466 |
Total Omega-6 | 5240.88 ± 1367.31 | 5196.37 ± 889.10 | 0.877 |
LA (C18:2 w6) | 4244.0 ± 1198.49 | 4278.84 ± 754.12 | 0.877 |
GLA (C18:3 w6) | 12.23 ± 7.05 | 10.50 ± 4.80 | 0.310 |
DGLA (C20:3 w6) | 281.97 ± 90.0 | 249.93 ± 69.32 | 0.112 |
AA (C20:4 w6) | 700.02 ± 250.94 | 657.03 ± 194.62 | 0.442 |
Omega-9 (Oleic acid, C18:1 w9) | 3075.58 ± 950.43 | 2784.65 ± 795.29 | 0.184 |
Saturated fatty acid | 5746.79 ± 1578.68 | 5442.43 ± 1140.38 | 0.377 |
Myristic acid, C14:0 | 151.08 ± 115.13 | 166.46 ± 76.30 | 0.188 |
Palmitic acid, C16:0 | 4834.32 ± 1341.59 | 4504.96 ± 1003.46 | 0.261 |
Stearic acid, C18:0 | 756.17 ± 185.33 | 774.21 ± 126.48 | 0.648 |
Monounsaturated fatty acid | 3511.52 ± 1075.18 | 3102.25 ± 881.53 | 0.095 |
Palmitoleic acid (C16:1 w7) | 422.94 ± 195.99 | 325.71 ± 111.03 | 0.037 |
Oleic acid (C18:1 w9) | 3075.58 ± 950.43 | 2784.65 ± 795.29 | 0.184 |
Total fatty acid | 14,974.67 ± 4052.2 | 14,275.59 ± 2883.22 | 0.420 |